Loading News...
Volver al Panel

10x Genomics, Inc. (TXG)

Valores intradiarios en tiempo real

Resumen del Mercado

From:
To:
TXG Intraday
No data available
SímboloTXG
Fecha de SalidaSep 12, 2019
CEODr. Serge Saxonov Ph.D.
Empleados a Tiempo Completo1.2k
SectorHealthcare
IndustriaMedical Devices
PaísUnited States
BolsaNasdaqGS
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Rendimiento
PeríodoRentabilidad %Cambio de Valor
1 Día
+2.42%
+1.69 US$
5 Días
+2.26%
+1.58 US$
1 Mes
-5.53%
-4.18 US$
6 Meses
+223.55%
+49.36 US$

Analizando el Mercado con IA

Evaluando los últimos 30 días de historial y métricas fundamentales de TXG...

Estadísticas Clave
Cap. de Mercado
9.32B
Relación P/E
N/A
Rend. de Div.
0.00%
Máx. 52 Semanas
$102.81
Mín. 52 Semanas
$12.34

Consenso de Analistas

CONSENSOCompra
ALCISTA633.3%
NEUTRAL1266.7%
BAJISTA00.0%

Objetivos de Precios de Analistas a 52 Semanas

Objetivo Mín.
$50.00
Objetivo Máx.
$110.00
Actual$71.44
Objetivo Prom.$77.50

Recomendaciones de Analistas

Precio Objetivo:$77.50($50.00 - $110.00)
FirmaCalificaciónPrecio ObjetivoPotencial de AlzaFecha
TD CowenHold$70.00-2.02%13/10/2026
Morgan StanleyEqual-Weight$70.00-2.02%13/10/2026
Canaccord GenuityBuy$100.00+39.98%12/10/2026
BarclaysOverweight$110.00+53.98%7/10/2026
Leerink PartnersMarket Perform$90.00+25.98%29/9/2026
Piper SandlerNeutral$80.00+11.98%28/9/2026
Argus ResearchBuy$110.00+53.98%28/9/2026
UBSNeutral$68.00-4.82%9/9/2026
RBC CapitalSector Perform$70.00-2.02%1/9/2026
Stephens & Co.Overweight$65.00-9.01%12/8/2026
Pensamientos de la Comunidad

Comparta su análisis y sentimiento sobre TXG

Únase a la comunidad para compartir su análisis